How should we measure nutrition-induced improvements in memory?

SummaryThere is a basic distinction between declarative memories, which can be stated verbally, and non-declarative memory, such as how to ride a bicycle, which cannot be expressed in words. With age it is the performance of declarative memory, particularly episodic memory that requires recall of events placed in time, that declines. As memory is not a unitary phenomenon, it should be ideally monitored using a range of tests that reflect theoretical conceptions of the topic. If circumstances demand the use of a single test then a measure of episodic memory is suggested. When it proves only possible to use a rating scale it should be ensured that memory is distinguished from other aspects of cognition and that different types of memory are not confused. The tests used, and the form in which they are used, need to be chosen to be of appropriate difficulty for the sample studied. A major conclusion is that the selection of the measure of memory used in the study of a dietary intervention should never be routine. It is inevitable that the form of the test used will need to be chosen carefully for the population being studied.

[1]  B. Uttl Age-Related Changes in Event-Cued Prospective Memory Proper , 2005 .

[2]  P. Smith,et al.  A jigsaw puzzle theory of memory , 2000, Memory.

[3]  B. Uttl,et al.  Measurement of Individual Differences , 2005, Psychological science.

[4]  Andy C. H. Lee,et al.  “Pray or Prey?” Dissociation of Semantic Memory Retrieval from Episodic Memory Processes Using Positron Emission Tomography and a Novel Homophone Task , 2002, NeuroImage.

[5]  R. Mattson,et al.  Test-retest comparability and control subject data for the Rey-Auditory Verbal Learning Test and Rey-Osterrieth/Taylor Complex Figures. , 1992, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[6]  A. Baddeley The episodic buffer: a new component of working memory? , 2000, Trends in Cognitive Sciences.

[7]  P. Rubé,et al.  L’examen Clinique en Psychologie , 1959 .

[8]  R. Mayeux,et al.  Antioxidant vitamin intake and risk of Alzheimer disease. , 2003, Archives of neurology.

[9]  E. Pfeiffer A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients † , 1975, Journal of the American Geriatrics Society.

[10]  K. Herholz,et al.  Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. , 1994, Dementia.

[11]  M. Salamero,et al.  Reliability and clinical usefulness of the short-forms of the Wechsler memory scale (revised) in patients with epilepsy , 2000, Epilepsy Research.

[12]  R. Logie,et al.  Prospective and retrospective memory in normal ageing and dementia: A questionnaire study , 2000, Memory.

[13]  J. Yesavage,et al.  Effects of phosphatidylserine in age‐associated memory impairment , 1991, Neurology.

[14]  B. Shahani,et al.  Assessing segmental excitability after acute rostral lesions , 1978, Neurology.

[15]  G. Huffmann,et al.  The treatment of delirium tremens and of incomplete alcoholic delirium ‐ a brief history , 1986, Acta psychiatrica Scandinavica. Supplementum.

[16]  T. Crook,et al.  Effects of phosphatidylserine in Alzheimer's disease. , 1992, Psychopharmacology bulletin.

[17]  HERMAN BUSCHKE,et al.  Evaluating storage, retention, and retrieval in disordered memory and learning , 1974, Neurology.

[18]  K. Haaland,et al.  Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. , 1997, The American journal of clinical nutrition.

[19]  J. Jolles,et al.  The Influence of Soy-derived Phosphatidylserine on Cognition in Age-Associated Memory Impairment , 2001, Nutritional neuroscience.

[20]  D. Bennett,et al.  Dietary Intake of Antioxidant Nutrients and the Risk of Incident Alzheimer Disease in a Biracial Community Study , 2022 .

[21]  C Jonker,et al.  LIMITATIONS OF THE MINI‐MENTAL STATE EXAMINATION IN DIAGNOSING DEMENTIA IN GENERAL PRACTICE , 1997, International journal of geriatric psychiatry.

[22]  A. Panerai,et al.  Effects of phosphatidylserine therapy in geriatric patients with depressive disorders , 1990, Acta psychiatrica Scandinavica.

[23]  J. Hodges,et al.  Identification of famous faces and famous names in early Alzheimer's disease. Relationship to anterograde episodic and general semantic memory. , 1996, Brain : a journal of neurology.

[24]  H. Brodaty,et al.  The GPCOG: A New Screening Test for Dementia Designed for General Practice , 2002, Journal of the American Geriatrics Society.

[25]  R. Ortega,et al.  Dietary intake and cognitive function in a group of elderly people. , 1997, The American journal of clinical nutrition.

[26]  B. Axelrod,et al.  Effects of Practice in Repeated Administrations of the Wechsler Memory Scale-Revised in Normal Adults , 1998, Assessment.

[27]  K. Boone,et al.  Handbook of Normative Data for Neuropsychological Assessment , 1999 .

[28]  A. Hofman,et al.  Dietary Intake of Antioxidants and Risk of Alzheimer Disease , 2002 .

[29]  Cheryl L Grady,et al.  Changes in memory processing with age , 2000, Current Opinion in Neurobiology.

[30]  K. Hall,et al.  Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. , 1999, American journal of epidemiology.

[31]  John Crawford,et al.  The Prospective and Retrospective Memory Questionnaire (PRMQ): Normative data and latent structure in a large non-clinical sample , 2003, Memory.

[32]  David A. Balota,et al.  Memory changes in healthy older adults. , 2000 .

[33]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[34]  H. Tuokko,et al.  The 12-Item Buschke Memory Test: Appropriate for Use Across Levels of Impairment , 2002, Applied neuropsychology.

[35]  M. Gorfine,et al.  An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. , 2000, The Israel journal of psychiatry and related sciences.

[36]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[37]  Donald G. MacKay,et al.  On the tip of the tongue: What causes word finding failures in young and older adults? , 1991 .

[38]  M. Angermeyer,et al.  Mild cognitive impairment 1 – a review of prevalence, incidence and outcome according to current approaches , 2002, Acta psychiatrica Scandinavica.

[39]  C. Lyketsos,et al.  Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study. , 1999, The American journal of psychiatry.

[40]  Richard S. J. Frackowiak,et al.  Brain regions associated with acquisition and retrieval of verbal episodic memory , 1994, Nature.

[41]  M. Rossor,et al.  The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[42]  W. Heiss,et al.  Effect of Phosphatidylserine on Cerebral Glucose Metabolism in Alzheimer's Disease , 1990 .

[43]  S. Borson,et al.  Brief Screening Tests for Dementia , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[44]  H. Stähelin,et al.  The Relation Between Antioxidants and Memory Performance in the Old and Very Old , 1997, Journal of the American Geriatrics Society.

[45]  Nicole D. Anderson,et al.  Memory in the aging brain , 2000 .

[46]  C. Brayne,et al.  The Cambridge Project for Later Life: design and preliminary results. , 1992, Neuroepidemiology.

[47]  Association of vitamin E and C supplement use with cognitive function and dementia in elderly men , 2000 .

[48]  L. Amaducci,et al.  A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? , 1996, Pharmacological research.

[49]  David Wechsler,et al.  Wechsler Memory scale. , 2005 .

[50]  R. Thomson,et al.  A systematic review of cognitive decline in the general elderly population , 2003, International journal of geriatric psychiatry.

[51]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[52]  Denis A. Evans,et al.  Vitamin E and cognitive decline in older persons. , 2002, Archives of neurology.

[53]  L. Marinangeli,et al.  Cognitive decline in the elderly: A double- blind, placebo- controlled multicenter study on efficacy of phosphatidylserine administration , 1993, Aging.

[54]  R. Sram,et al.  Effect of antioxidant supplementation in an elderly population. , 1993, Basic life sciences.

[55]  R. Doody,et al.  Establishing the limits of the Mini-Mental State. Examination of 'subtests'. , 1992, Archives of neurology.

[56]  D. Guidolin,et al.  Dendritic spine loss in hippocampus of aged rats. Effect of brain phosphatidylserine administration , 1987, Neurobiology of Aging.

[57]  L. Nilsson Memory function in normal aging , 2003, Acta neurologica Scandinavica. Supplementum.

[58]  A. Hurlet,et al.  Double‐blind randomized controlled study of phosphatidylserine in senile demented patients , 1986, Acta neurologica Scandinavica.

[59]  R. Ortega,et al.  Cognitive function in elderly people is influenced by vitamin E status. , 2002, The Journal of nutrition.

[60]  S. Ferris,et al.  Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .

[61]  Andrew P. Smith,et al.  Anti‐oxidant vitamins and mental performance of the elderly , 1999 .

[62]  P. Maruff,et al.  The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment , 2000, Neuroscience & Biobehavioral Reviews.

[63]  N. Kathmann,et al.  Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type , 1992, European Neuropsychopharmacology.